Immune responses induced by heat killed Saccharomyces cerevisiae: A vaccine against fungal infection

Vaccine

Volumn 29, Issue 9, 2011, Pages 1745-1753

  Liu, Min ^a,b,c   Clemons, Karl V ^a,b,c   Bigos, Marty ^b   Medovarska, Izabela ^d   Brummer, Elmer ^a,b,c   Stevens, David A ^a,b,c  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b STANFORD UNIVERSITY   (United States)

^c SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^d INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Fungal infection; Saccharomyces cerevisiae; Vaccines

Indexed keywords

FUNGUS ANTIBODY; FUNGUS VACCINE; GAMMA INTERFERON; GLUCAN; HEAT KILLED SACCHAROMYCES CEREVISIAE VACCINE; INTERLEUKIN 17; INTERLEUKIN 6; MANNAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; ASPERGILLOSIS; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIVISION; CELL PROLIFERATION; CELLULAR IMMUNITY; COCCIDIOIDOMYCOSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LUNG LAVAGE; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SPLEEN CELL; VACCINATION;

EID: 79952707321     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.119     Document Type: Article

References (51)

1. Robbins JB, Schneerson R. Polysaccharide-protein conjugates: a new generation of vaccines. J Infect Dis 1990;161(5):821-32.
2. Torosantucci A, Bromuro C, Chiani P, De Bernardis F, Berti F, Galli C, et al. A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 2005;202(5):597-606.
3. Bernstein MB, Chakraborty M, Wansley EK, Guo Z, Franzusoff A, Mostbock S, et al. Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine 2008;26(4):509-21.
4. Remondo C, Cereda V, Mostbock S, Sabzevari H, Franzusoff A, Schlom J, et al. Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen. Vaccine 2009;27(7):987-94.
5. Capilla J, Clemons KV, Liu M, Levine HB, Stevens DA. Saccharomyces cerevisiae as a vaccine against coccidioidomycosis. Vaccine 2009;27(27):3662-8.
6. Capilla J, Clemons KV, Stevens DA. The friend of man a friend again? Sac-charomyces as a vaccine against invasive aspergillosis. In: 47th intersci. conf. antimicrob. agents chemother. 2007 [Abstract # G-1708].
7. Johansen M, Danielle D, Liu M, Clemons K, Stevens D. Efficacy of different strains of Saccharomyces cerevisiae as a vaccine against systemic aspergillosis. In: 4th advances against aspergillosis. 2010 [Abstract #22].
8. Liu M, Clemons K, Bigos M, Stevens D. Immune responses induced by heat killed yeast, a vaccine against aspergillosis in mice. In: 4th advances against aspergillosis. 2010 [Abstract #20].
9. Liu M, Clemons K, Stevens D. Saccharomyces as a vaccine against invasive aspergillosis is enhanced by alum but is not mouse strain or Saccharomyces species specific. In: 4th advances against aspergillosis. 2010 [Abstract # 21].
10. Stevens DA, Clemons KV, Liu M.Developingavaccine againstaspergillosis. Med Mycol 2010, doi:10.3109/13693786.2010.497775 [Epub ahead of print] PMID: 20608783.
11. Liu M, Clemons K, Johasen M, Martinez M, Chen V, Stevens D. Saccharomyces as a vaccine against systemic candidiasis. In: 50th interscience conference on antimicrobial agents and chemotherapy. 2010 [Abstract # G1-1656].
12. Sugar AM, Brummer E, Stevens DA. Murine pulmonary macrophages: evaluation of lung lavage fluids, miniaturized monolayers, and candidacidal activity. Am Rev Respir Dis 1983;127(1):110-2.
13. -5 M mercaptoethanol. J Immunol Methods 1977;17(3-4):319-27.
14. Libjakova L, Bystricky S, Lizicarova I, Paulovicova E, Machova E. Evaluation of different mannan polysaccharide usage in enzyme-linked immunosor-bent assay for specific antibodies determination. J Pharm Biomed Anal 2007;45(3):521-5.
15. Ampel NM, Christian L. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen. Med Mycol 2000;38(2):127-32.
16. Fierer J, Waters C, Walls L. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice. J Infect Dis 2006;193(9):1323-31.
17. Ramadan G, Davies B, Kurup VP, Keever-Taylor CA. Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen. Clin Exp Immunol 2005;140(1): 81-91.
18. Spellberg B, Ibrahim AS, Lin L, Avanesian V, Fu Y, Lipke P, et al. Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity. J Infect Dis 2008;197(7):967-71.
19. Wuthrich M, Filutowicz HI, Warner T, Deepe Jr GS, Klein BS. Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med 2003;197(11): 1405-16.
20. Zheng M,Ramsay AJ, Robichaux MB, Norris KA, Kliment C,Crowe C,etal. CD4+ T cell-independent DNA vaccination against opportunistic infections.J Clin Invest 2005;115(12):3536-44.
21. Wong P, Pamer EG. CD8+ T cell responses to infectious pathogens. Annu Rev Immunol 2003;21:29-70.
22. Johansen P, Senti G, Martinez Gomez JM, Wuthrich B, Bot A, Kundig TM. Heat denaturation, a simple method to improve the immunotherapeutic potential of allergens. Eur J Immunol 2005;35(12):3591-8.
23. Stevens DA, Brummer E, Clemons KV. Interferon-gamma as an antifungal. J Infect Dis 2006;194(Suppl 1):S33-7.
24. Roilides E, Katsifa H, Walsh TJ. Pulmonary host defences against Aspergillus fumigatus. Res Immunol 1998;149(4-5):454-65 [discussion 523-4].
25. Cole GT, Xue JM, Okeke CN, Tarcha EJ, Basrur V, Schaller RA, et al. A vaccine against coccidioidomycosis is justified and attainable. Med Mycol 2004;42(3):189-216.
26. Brummer E, Capilla J, Bythadka L, Stevens DA. Production of IL-6, in contrast to other cytokines and chemokines, in macrophage innate immune responses: effect of serum and fungal (Blastomyces) challenge. Cytokine 2007;39(3):163-70.
27. Cox RA, Magee DM. Production of tumor necrosis factor alpha, interleukin-1 alpha, and interleukin-6 during murine coccidioidomycosis. Infect Immun 1995;63(10):4178-80.
28. Cenci E, Mencacci A, Casagrande A, Mosci P, Bistoni F, Romani L. Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis. J Infect Dis 2001;184(5):610-7.
29. Bettelli E, Carrier Y,Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH 17 and regulatory T cells. Nature 2006;441(7090):235-8.
30. Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, Ramsay AJ, et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 2003;170(9): 4432-6.
31. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001;194(4):519-27.
32. Zelante T,DeLuca A, D'AngeloC,Moretti S, Romani L. IL-17/Th17in anti-fungal immunity: what's new? Eur J Immunol 2009;39(3):645-8.
33. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004;190(3):624-31.
34. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, Koenen HJ, Cheng SC, Joosten I, et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009;5(4):329-40.
35. Oukka M. Th17 cells in immunity and autoimmunity. Ann Rheum Dis 2008;67(Suppl 3):iii26-9.
36. Leenen PJ, Canono BP, Drevets DA, Voerman JS, Campbell PA. TNF-alpha and IFN-gamma stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J Immunol 1994;153(11): 5141-7.
37. Mehrad B, Strieter RM, Standiford TJ. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. J Immunol 1999;162(3): 1633-40.
38. Saegusa S, Totsuka M, Kaminogawa S, Hosoi T. Saccharomyces cerevisiae and Candida albicans stimulate cytokine secretion from human neutrophil-like HL-60 cells differentiated with retinoic acidordimethylsulfoxide. Biosci Biotechnol Biochem 2009;73(12):2600-8.
39. Levitz SM. Innate recognition of fungal cell walls. PLoS Pathog 2010;6(4):e1000758.
40. Paulovicova E, Machova E, Tulinska J, Bystricky S. Cell and antibody mediated immunity induced by vaccination with novel Candida dubliniensis mannan immunogenic conjugate. Int Immunopharmacol 2007;7(10):1325-33.
41. Han Y, Riesselman MH, Cutler JE. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect Immun 2000;68(3):1649-54.
42. Han Y, Ulrich MA, Cutler JE. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J Infect Dis 1999;179(6):1477-84.
43. Ishibashi K, Yoshida M, Nakabayashi I, Shinohara H, Miura NN, Adachi Y, et al. Role of anti-beta-glucan antibodyin host defense against fungi. FEMS Immunol Med Microbiol 2005;44(1):99-109.
44. Casadevall A, Pirofski LA. Antibody-mediated protection through cross-reactivity introduces afungal heresy into immunological dogma. Infect Immun 2007;75(11):5074-8.
45. Chakhtoura M, Rahal E, Halas Y, Al-Sabbagh Z, Abdelnoor AM. Preparation of anti-Aspergillus fumigatus antibodies in egg laying hens and their protective efficacy in BALB/c mice. J Appl Res 2008;8:168-77.
46. Chaturvedi AK, Kavishwar A, Shiva Keshava GB, Shukla PK. Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glyco-protein protects against experimental murine aspergillosis. Clin Diagn Lab Immunol 2005;12(9):1063-8.
47. Paulovicova E, Bystricky S, Masarova J, Machova E, Mislovicova D. Immune response to Saccharomyces cerevisiae mannan conjugate in mice. Int Immunopharmacol 2005;5(12):1693-8.
48. Young SH, Roberts JR, Antonini JM. Pulmonary exposure to 1 → 3-beta-glucan alters adaptive immune responses in rats. Inhal Toxicol 2006;18(11):865-74.
49. Xue J, Chen X, Selby D, Hung CY, Yu JJ, Cole GT. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis. Infect Immun 2009;77(8):3196-208.
50. Orsborn KI, Shubitz LF, Peng T, Kellner EM, Orbach MJ, Haynes PA, et al. Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate. Infect Immun 2006;74(3):1865-72.
51. Ito JI, Lyons JM, Hong TB, Tamae D, Liu YK, Wilczynski SP, et al. Vaccinations with recombinant variantsofAspergillus fumigatus allergen Asp f 3 protectmice against invasive aspergillosis. Infect Immun 2006;74(9):5075-84.